SMMT · Summit Therapeutics Inc. · Fails to Deliver
$11.82
-2.33 (-16.47%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Going-concern doubt
— cleared Nov 4, 2026
The latest filing no longer states the doubt (first flagged Jul 23, 2026).
View the 10-Q filed Nov 4, 2026Market Cap
$9.45B
Shares
799.76M
Volume · Nov 16
24.45M
Avg daily vol (3M)
6.46M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-23 | 557 | $15.55 | $8,661 |
| 2026-10-09 | 7,167 | $17.17 | $123,057 |
| 2026-10-08 | 333,661 | $17.95 | $5,989,215 |
| 2026-10-07 | 804 | $17.31 | $13,917 |
| 2026-09-29 | 10,139 | $15.48 | $156,952 |
| 2026-09-24 | 63,894 | $16.45 | $1,051,056 |
| 2026-09-22 | 5 | $16.90 | $85 |
| 2026-09-21 | 1,094,668 | $17.85 | $19,539,824 |
| 2026-09-18 | 3,550 | $17.72 | $62,906 |
| 2026-09-17 | 9,669 | $17.30 | $167,274 |
| 2026-09-16 | 17,943 | $17.40 | $312,208 |
| 2026-09-15 | 4,338 | $18.42 | $79,906 |
| 2026-09-14 | 2,062 | $17.55 | $36,188 |
| 2026-09-09 | 341,010 | $17.28 | $5,892,653 |
| 2026-09-08 | 29,684 | $17.61 | $522,735 |
| 2026-09-04 | 66,143 | $17.13 | $1,133,030 |
| 2026-09-03 | 140,668 | $14.60 | $2,053,753 |
| 2026-08-26 | 4,447 | $13.36 | $59,412 |
| 2026-08-25 | 28,983 | $12.73 | $368,954 |
Showing 1–19 of 19 settlements
Key facts
CIK
1599298
CUSIP
86627T108
13F (30d)
265 filings
248 filers
Visit website
Investor relations